Oren Nissim, Brook-Ai – Figuring Out RPM

Key Takeaways

• 50% hypertension control in ten weeks
• ~50% reduction in CHF readmissions
• Raised $28M Series B, $40M total funding
• Aims to lower readmissions, improve care adherence
• Presented strategy at VIVE 2026 conference

Summary

Brook.ai, led by CEO Oren Nissim, is scaling its remote patient monitoring (RPM) platform to cut hospital readmissions and improve care plan adherence. The company reports over 50% of its hypertension cohort achieving control within ten weeks and a roughly 50% drop in congestive heart failure readmissions. Late 2025 it closed a $28 million Series B round, bringing total capital to $40 million. Nissim outlined these results and the firm’s growth strategy at the VIVE conference in February 2026.

Pulse Analysis

Brook.ai’s remote patient monitoring (RPM) platform is gaining traction as hospitals grapple with rising readmission penalties and the need for continuous care. By leveraging connected devices, AI‑driven analytics, and proactive outreach, the company claims more than half of its hypertension population reaches target blood pressure within ten weeks, while congestive heart failure (CHF) readmissions fall by roughly 50%. These outcomes align with broader industry data showing RPM can cut readmission rates by 20‑30 percent, underscoring the technology’s potential to improve both clinical results and cost efficiency.

The recent $28 million Series B injection, which lifts Brook.ai’s total financing to $40 million, signals strong investor confidence in its differentiated approach. Unlike generic RPM vendors, Brook.ai integrates predictive risk modeling that flags patients likely to deviate from care plans, enabling timely interventions. At the VIVE conference, Oren Nissim highlighted partnerships with major health systems and a roadmap that includes expanding into chronic disease management beyond hypertension and CHF. This capital boost will fund scaling of its data infrastructure, regulatory compliance, and market expansion into underserved regions where remote care can bridge access gaps.

For providers, Brook.ai’s results translate into tangible financial and operational benefits. Reduced readmissions lower Medicare penalties and free up bed capacity, while improved adherence can enhance quality metrics tied to reimbursement. Patients benefit from personalized, at‑home monitoring that reduces the burden of frequent clinic visits. As payers increasingly reward value‑based care, platforms like Brook.ai that demonstrate measurable outcomes are poised to become integral components of the evolving healthcare ecosystem.